Acute Occupational Exposure to Antineoplastic Agents
- 1 December 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 30 (12) , 984-987
- https://doi.org/10.1097/00043764-198812000-00020
Abstract
Antineoplastic agents may exhibit effects not only in patients therapeutically exposed, but also in health workers who prepare and administer these drugs. Concern to data has focused on long-term health consequences, including adverse reproductive outcomes, altered immunity, and increased cancer risk. The burgeoning use of these drugs for non-malignant illnesses has enlarged the health worker population at risk beyond oncology personnel to include professionals in immunology, rheumatology, nephrology, and dermatology. We report here two cases of hospital workers who experienced acute adverse health effects resulting from occupational exposure to antineoplastic drugs. We believe such acute events are under-reported, and that they demonstrate the need for physician awareness regarding their management.This publication has 9 references indexed in Scilit:
- Malignancy following treatment of rheumatoid arthritis with cyclophosphamideThe American Journal of Medicine, 1987
- Administration of monthly-pulse cyclophosphamide in multiple sclerosis patientsJournal of Neuroimmunology, 1987
- A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in NursesNew England Journal of Medicine, 1985
- Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome.Journal of Epidemiology and Community Health, 1985
- MONITORING EXPOSURE OF NURSING AND PHARMACY PERSONNEL TO CYTOTOXIC DRUGS: URINARY MUTATION ASSAYS AND URINARY PLATINUM AS MARKERS OF ABSORPTIONThe Lancet, 1984
- EXPOSURE OF PHARMACY PERSONNEL TO MUTAGENIC ANTI-NEOPLASTIC DRUGS1982
- CHROMOSOME ANALYSES OF NURSES HANDLING CYTOSTATIC AGENTS1981
- Percutaneous absorption of I,3-bis (2-chloroethyl)-I-nitrosourea (BCNU, carmustine) in mycosis fungoidesBritish Journal of Dermatology, 1977
- Teratogenic Effects of Combination ChemotherapyAnnals of Internal Medicine, 1974